SWIFT

Study of Whole Blood In Frontline Trauma

A trial of the clinical and cost-effectiveness of pre-hospital whole blood administration versus standard care for traumatic haemorrhage.

About the trial For investigators For participants

Recruited so far

472/848

participants

This study will look at whether giving another product instead of red blood cells and plasma pre-hospital will:

reduce the number of deaths 24 hours after injury
reduce the need for further large blood transfusions when patients get to hospital

The product that will be given is called whole blood (WB). It contains red blood cells, plasma and platelets (which help with clotting) all in one bag.

About the SWIFT trial

About the trial

Information on the background to this trial and what we are hoping to find.

Learn more

For investigators

Aims, eligibility criteria, and outcomes.

About criteria and outcomes

For participants

Find out more about what it means to take part.

What the study involves

Partners

Air Ambulances UK

Headquarters Defence Medical Services

Air Ambulance Kent Surrey Sussex

Dorset and Somerset Air Ambulance

Essex and Herts Air Ambulance

Great North Air Ambulance

Great Western Air Ambulance

Hampshire and Isle of Wight Air Ambulance

London’s Air Ambulance

Mid Anglia General Practitioner Accident Service (Magpas) Air Ambulance

North West Air Ambulance

Thames Valley Air Ambulance